nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—Pericarditis constrictive—Mesalazine—Crohn's disease	0.0838	0.212	CcSEcCtD
Bromocriptine—HTR7—enteric nervous system—Crohn's disease	0.0437	0.231	CbGeAlD
Bromocriptine—HTR7—myenteric nerve plexus—Crohn's disease	0.0331	0.175	CbGeAlD
Bromocriptine—HTR2A—enteric nervous system—Crohn's disease	0.0273	0.144	CbGeAlD
Bromocriptine—HTR2A—myenteric nerve plexus—Crohn's disease	0.0207	0.109	CbGeAlD
Bromocriptine—Pleurisy—Mesalazine—Crohn's disease	0.0164	0.0416	CcSEcCtD
Bromocriptine—Pericardial effusion—Mesalazine—Crohn's disease	0.00978	0.0248	CcSEcCtD
Bromocriptine—Pericarditis—Mesalazine—Crohn's disease	0.00928	0.0235	CcSEcCtD
Bromocriptine—Lung infiltration—Mesalazine—Crohn's disease	0.00855	0.0217	CcSEcCtD
Bromocriptine—Abdominal cramps—Mesalazine—Crohn's disease	0.00594	0.015	CcSEcCtD
Bromocriptine—Burning sensation—Mesalazine—Crohn's disease	0.00577	0.0146	CcSEcCtD
Bromocriptine—HTR7—mouth—Crohn's disease	0.00567	0.03	CbGeAlD
Bromocriptine—ADRA1D—epithelium—Crohn's disease	0.00554	0.0293	CbGeAlD
Bromocriptine—Dermatitis atopic—Mesalazine—Crohn's disease	0.00542	0.0137	CcSEcCtD
Bromocriptine—DRD5—lymphoid tissue—Crohn's disease	0.00532	0.0281	CbGeAlD
Bromocriptine—Pleural effusion—Mesalazine—Crohn's disease	0.00524	0.0133	CcSEcCtD
Bromocriptine—Amblyopia—Mesalazine—Crohn's disease	0.0052	0.0132	CcSEcCtD
Bromocriptine—Rhinorrhoea—Mesalazine—Crohn's disease	0.00495	0.0125	CcSEcCtD
Bromocriptine—Delirium—Mesalazine—Crohn's disease	0.00466	0.0118	CcSEcCtD
Bromocriptine—Vasculitis—Azathioprine—Crohn's disease	0.00451	0.0114	CcSEcCtD
Bromocriptine—HTR2B—smooth muscle tissue—Crohn's disease	0.00371	0.0196	CbGeAlD
Bromocriptine—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00369	0.00933	CcSEcCtD
Bromocriptine—HTR2B—skin of body—Crohn's disease	0.00366	0.0194	CbGeAlD
Bromocriptine—HTR7—epithelium—Crohn's disease	0.0033	0.0174	CbGeAlD
Bromocriptine—Alopecia—Mercaptopurine—Crohn's disease	0.00328	0.00831	CcSEcCtD
Bromocriptine—ADRA1A—epithelium—Crohn's disease	0.00318	0.0168	CbGeAlD
Bromocriptine—HTR7—smooth muscle tissue—Crohn's disease	0.00318	0.0168	CbGeAlD
Bromocriptine—Peptic ulcer—Prednisone—Crohn's disease	0.00318	0.00804	CcSEcCtD
Bromocriptine—Delusion—Prednisone—Crohn's disease	0.003	0.00759	CcSEcCtD
Bromocriptine—Lethargy—Mesalazine—Crohn's disease	0.00297	0.00753	CcSEcCtD
Bromocriptine—HTR2B—digestive system—Crohn's disease	0.00293	0.0155	CbGeAlD
Bromocriptine—Mania—Prednisone—Crohn's disease	0.00292	0.00739	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00291	0.00737	CcSEcCtD
Bromocriptine—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00289	0.00732	CcSEcCtD
Bromocriptine—Dermatitis atopic—Prednisone—Crohn's disease	0.00287	0.00726	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00273	0.00692	CcSEcCtD
Bromocriptine—Abdominal pain upper—Mesalazine—Crohn's disease	0.00266	0.00674	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00266	0.00674	CcSEcCtD
Bromocriptine—Abdominal discomfort—Azathioprine—Crohn's disease	0.00265	0.00671	CcSEcCtD
Bromocriptine—Oedema—Mercaptopurine—Crohn's disease	0.00264	0.00668	CcSEcCtD
Bromocriptine—ADRA2C—mammalian vulva—Crohn's disease	0.00263	0.0139	CbGeAlD
Bromocriptine—Cramp muscle—Mesalazine—Crohn's disease	0.00262	0.00664	CcSEcCtD
Bromocriptine—Nasopharyngitis—Mesalazine—Crohn's disease	0.0026	0.00659	CcSEcCtD
Bromocriptine—Skin disorder—Mercaptopurine—Crohn's disease	0.00256	0.00649	CcSEcCtD
Bromocriptine—Influenza—Mesalazine—Crohn's disease	0.00252	0.00637	CcSEcCtD
Bromocriptine—Dysphagia—Mesalazine—Crohn's disease	0.00252	0.00637	CcSEcCtD
Bromocriptine—Anorexia—Mercaptopurine—Crohn's disease	0.00251	0.00637	CcSEcCtD
Bromocriptine—HTR7—digestive system—Crohn's disease	0.00251	0.0133	CbGeAlD
Bromocriptine—Delirium—Prednisone—Crohn's disease	0.00247	0.00625	CcSEcCtD
Bromocriptine—ADRA1A—lymphoid tissue—Crohn's disease	0.00245	0.0129	CbGeAlD
Bromocriptine—Abdominal discomfort—Mesalazine—Crohn's disease	0.00241	0.00611	CcSEcCtD
Bromocriptine—Pollakiuria—Mesalazine—Crohn's disease	0.00232	0.00589	CcSEcCtD
Bromocriptine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00229	0.00581	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00228	0.00577	CcSEcCtD
Bromocriptine—Vasculitis—Prednisone—Crohn's disease	0.00217	0.00551	CcSEcCtD
Bromocriptine—Sinusitis—Mesalazine—Crohn's disease	0.00211	0.00533	CcSEcCtD
Bromocriptine—ADRA2A—mammalian vulva—Crohn's disease	0.0021	0.0111	CbGeAlD
Bromocriptine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00208	0.00528	CcSEcCtD
Bromocriptine—HTR2A—epithelium—Crohn's disease	0.00206	0.0109	CbGeAlD
Bromocriptine—Rhinitis—Mesalazine—Crohn's disease	0.00202	0.00511	CcSEcCtD
Bromocriptine—CYP1A2—digestive system—Crohn's disease	0.002	0.0106	CbGeAlD
Bromocriptine—Mediastinal disorder—Azathioprine—Crohn's disease	0.00199	0.00505	CcSEcCtD
Bromocriptine—Oedema peripheral—Mesalazine—Crohn's disease	0.00198	0.00503	CcSEcCtD
Bromocriptine—HTR2A—smooth muscle tissue—Crohn's disease	0.00198	0.0105	CbGeAlD
Bromocriptine—Connective tissue disorder—Mesalazine—Crohn's disease	0.00198	0.00501	CcSEcCtD
Bromocriptine—Arrhythmia—Azathioprine—Crohn's disease	0.00198	0.005	CcSEcCtD
Bromocriptine—Alopecia—Azathioprine—Crohn's disease	0.00195	0.00495	CcSEcCtD
Bromocriptine—Eye disorder—Mesalazine—Crohn's disease	0.00188	0.00477	CcSEcCtD
Bromocriptine—Tinnitus—Mesalazine—Crohn's disease	0.00188	0.00476	CcSEcCtD
Bromocriptine—Cardiac disorder—Mesalazine—Crohn's disease	0.00187	0.00473	CcSEcCtD
Bromocriptine—Angiopathy—Mesalazine—Crohn's disease	0.00183	0.00463	CcSEcCtD
Bromocriptine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00182	0.0046	CcSEcCtD
Bromocriptine—Diarrhoea—Mercaptopurine—Crohn's disease	0.0018	0.00457	CcSEcCtD
Bromocriptine—Alopecia—Mesalazine—Crohn's disease	0.00178	0.00451	CcSEcCtD
Bromocriptine—Diabetes mellitus—Prednisone—Crohn's disease	0.00177	0.00449	CcSEcCtD
Bromocriptine—Mental disorder—Mesalazine—Crohn's disease	0.00176	0.00447	CcSEcCtD
Bromocriptine—Tension—Mesalazine—Crohn's disease	0.00172	0.00436	CcSEcCtD
Bromocriptine—Dysgeusia—Mesalazine—Crohn's disease	0.00172	0.00435	CcSEcCtD
Bromocriptine—Nervousness—Mesalazine—Crohn's disease	0.0017	0.00431	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Prednisone—Crohn's disease	0.0017	0.0043	CcSEcCtD
Bromocriptine—Muscle spasms—Mesalazine—Crohn's disease	0.00169	0.00427	CcSEcCtD
Bromocriptine—Vomiting—Mercaptopurine—Crohn's disease	0.00168	0.00425	CcSEcCtD
Bromocriptine—HTR2B—lymph node—Crohn's disease	0.00167	0.00885	CbGeAlD
Bromocriptine—Rash—Mercaptopurine—Crohn's disease	0.00166	0.00421	CcSEcCtD
Bromocriptine—Dermatitis—Mercaptopurine—Crohn's disease	0.00166	0.00421	CcSEcCtD
Bromocriptine—Vision blurred—Mesalazine—Crohn's disease	0.00165	0.00419	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00163	0.00412	CcSEcCtD
Bromocriptine—Vertigo—Mesalazine—Crohn's disease	0.00158	0.00399	CcSEcCtD
Bromocriptine—Syncope—Mesalazine—Crohn's disease	0.00157	0.00398	CcSEcCtD
Bromocriptine—Lethargy—Prednisone—Crohn's disease	0.00157	0.00398	CcSEcCtD
Bromocriptine—Nausea—Mercaptopurine—Crohn's disease	0.00157	0.00397	CcSEcCtD
Bromocriptine—HTR2A—digestive system—Crohn's disease	0.00156	0.00827	CbGeAlD
Bromocriptine—Infection—Azathioprine—Crohn's disease	0.00156	0.00395	CcSEcCtD
Bromocriptine—Loss of consciousness—Mesalazine—Crohn's disease	0.00154	0.0039	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00154	0.0039	CcSEcCtD
Bromocriptine—Skin disorder—Azathioprine—Crohn's disease	0.00153	0.00386	CcSEcCtD
Bromocriptine—Hypertension—Mesalazine—Crohn's disease	0.00151	0.00383	CcSEcCtD
Bromocriptine—Psychotic disorder—Prednisone—Crohn's disease	0.0015	0.00381	CcSEcCtD
Bromocriptine—Anxiety—Mesalazine—Crohn's disease	0.00149	0.00377	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00148	0.00375	CcSEcCtD
Bromocriptine—Hypotension—Azathioprine—Crohn's disease	0.00147	0.00372	CcSEcCtD
Bromocriptine—Dry mouth—Mesalazine—Crohn's disease	0.00146	0.0037	CcSEcCtD
Bromocriptine—CYP3A4—digestive system—Crohn's disease	0.00145	0.00766	CbGeAlD
Bromocriptine—Confusional state—Mesalazine—Crohn's disease	0.00144	0.00365	CcSEcCtD
Bromocriptine—Oedema—Mesalazine—Crohn's disease	0.00143	0.00362	CcSEcCtD
Bromocriptine—Infection—Mesalazine—Crohn's disease	0.00142	0.0036	CcSEcCtD
Bromocriptine—Shock—Mesalazine—Crohn's disease	0.00141	0.00357	CcSEcCtD
Bromocriptine—Nervous system disorder—Mesalazine—Crohn's disease	0.0014	0.00355	CcSEcCtD
Bromocriptine—Tachycardia—Mesalazine—Crohn's disease	0.0014	0.00354	CcSEcCtD
Bromocriptine—Skin disorder—Mesalazine—Crohn's disease	0.00139	0.00352	CcSEcCtD
Bromocriptine—Anorexia—Mesalazine—Crohn's disease	0.00136	0.00345	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00136	0.00344	CcSEcCtD
Bromocriptine—ABCB1—epithelium—Crohn's disease	0.00135	0.00712	CbGeAlD
Bromocriptine—Hypotension—Mesalazine—Crohn's disease	0.00134	0.00339	CcSEcCtD
Bromocriptine—ADRA2C—lymph node—Crohn's disease	0.00132	0.00696	CbGeAlD
Bromocriptine—Feeling abnormal—Azathioprine—Crohn's disease	0.00129	0.00328	CcSEcCtD
Bromocriptine—Insomnia—Mesalazine—Crohn's disease	0.00129	0.00328	CcSEcCtD
Bromocriptine—Paraesthesia—Mesalazine—Crohn's disease	0.00129	0.00325	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00128	0.00325	CcSEcCtD
Bromocriptine—Dyspnoea—Mesalazine—Crohn's disease	0.00128	0.00323	CcSEcCtD
Bromocriptine—Somnolence—Mesalazine—Crohn's disease	0.00127	0.00322	CcSEcCtD
Bromocriptine—Dyspepsia—Mesalazine—Crohn's disease	0.00126	0.00319	CcSEcCtD
Bromocriptine—Decreased appetite—Mesalazine—Crohn's disease	0.00124	0.00315	CcSEcCtD
Bromocriptine—Body temperature increased—Azathioprine—Crohn's disease	0.00124	0.00315	CcSEcCtD
Bromocriptine—Abdominal pain—Azathioprine—Crohn's disease	0.00124	0.00315	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00124	0.00313	CcSEcCtD
Bromocriptine—Fatigue—Mesalazine—Crohn's disease	0.00123	0.00312	CcSEcCtD
Bromocriptine—Constipation—Mesalazine—Crohn's disease	0.00122	0.0031	CcSEcCtD
Bromocriptine—Feeling abnormal—Mesalazine—Crohn's disease	0.00118	0.00299	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Prednisone—Crohn's disease	0.00117	0.00296	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00117	0.00296	CcSEcCtD
Bromocriptine—ABCB1—mammalian vulva—Crohn's disease	0.00117	0.00618	CbGeAlD
Bromocriptine—Myocardial infarction—Prednisone—Crohn's disease	0.00116	0.00295	CcSEcCtD
Bromocriptine—Urticaria—Mesalazine—Crohn's disease	0.00114	0.00288	CcSEcCtD
Bromocriptine—Abdominal pain—Mesalazine—Crohn's disease	0.00113	0.00287	CcSEcCtD
Bromocriptine—Body temperature increased—Mesalazine—Crohn's disease	0.00113	0.00287	CcSEcCtD
Bromocriptine—Bradycardia—Prednisone—Crohn's disease	0.00109	0.00275	CcSEcCtD
Bromocriptine—Diarrhoea—Azathioprine—Crohn's disease	0.00108	0.00272	CcSEcCtD
Bromocriptine—Hallucination—Prednisone—Crohn's disease	0.00106	0.00269	CcSEcCtD
Bromocriptine—ADRA2A—lymph node—Crohn's disease	0.00105	0.00556	CbGeAlD
Bromocriptine—Connective tissue disorder—Prednisone—Crohn's disease	0.00105	0.00265	CcSEcCtD
Bromocriptine—Dizziness—Azathioprine—Crohn's disease	0.00104	0.00263	CcSEcCtD
Bromocriptine—ABCB1—lymphoid tissue—Crohn's disease	0.00104	0.00549	CbGeAlD
Bromocriptine—Asthenia—Mesalazine—Crohn's disease	0.00103	0.0026	CcSEcCtD
Bromocriptine—ABCB1—digestive system—Crohn's disease	0.00103	0.00542	CbGeAlD
Bromocriptine—Vomiting—Azathioprine—Crohn's disease	0.000999	0.00253	CcSEcCtD
Bromocriptine—Eye disorder—Prednisone—Crohn's disease	0.000996	0.00252	CcSEcCtD
Bromocriptine—Rash—Azathioprine—Crohn's disease	0.000991	0.00251	CcSEcCtD
Bromocriptine—Dermatitis—Azathioprine—Crohn's disease	0.00099	0.00251	CcSEcCtD
Bromocriptine—Headache—Azathioprine—Crohn's disease	0.000984	0.00249	CcSEcCtD
Bromocriptine—Diarrhoea—Mesalazine—Crohn's disease	0.000979	0.00248	CcSEcCtD
Bromocriptine—Angiopathy—Prednisone—Crohn's disease	0.000967	0.00245	CcSEcCtD
Bromocriptine—Arrhythmia—Prednisone—Crohn's disease	0.000952	0.00241	CcSEcCtD
Bromocriptine—Dizziness—Mesalazine—Crohn's disease	0.000946	0.0024	CcSEcCtD
Bromocriptine—Alopecia—Prednisone—Crohn's disease	0.000942	0.00239	CcSEcCtD
Bromocriptine—Mental disorder—Prednisone—Crohn's disease	0.000934	0.00236	CcSEcCtD
Bromocriptine—Nausea—Azathioprine—Crohn's disease	0.000933	0.00236	CcSEcCtD
Bromocriptine—Vomiting—Mesalazine—Crohn's disease	0.00091	0.0023	CcSEcCtD
Bromocriptine—Rash—Mesalazine—Crohn's disease	0.000902	0.00229	CcSEcCtD
Bromocriptine—Dermatitis—Mesalazine—Crohn's disease	0.000902	0.00228	CcSEcCtD
Bromocriptine—Headache—Mesalazine—Crohn's disease	0.000897	0.00227	CcSEcCtD
Bromocriptine—Vision blurred—Prednisone—Crohn's disease	0.000874	0.00221	CcSEcCtD
Bromocriptine—Agitation—Prednisone—Crohn's disease	0.000853	0.00216	CcSEcCtD
Bromocriptine—Nausea—Mesalazine—Crohn's disease	0.00085	0.00215	CcSEcCtD
Bromocriptine—Vertigo—Prednisone—Crohn's disease	0.000834	0.00211	CcSEcCtD
Bromocriptine—Syncope—Prednisone—Crohn's disease	0.000832	0.00211	CcSEcCtD
Bromocriptine—Loss of consciousness—Prednisone—Crohn's disease	0.000815	0.00207	CcSEcCtD
Bromocriptine—Convulsion—Prednisone—Crohn's disease	0.000804	0.00204	CcSEcCtD
Bromocriptine—Hypertension—Prednisone—Crohn's disease	0.000801	0.00203	CcSEcCtD
Bromocriptine—Anxiety—Prednisone—Crohn's disease	0.000787	0.00199	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000784	0.00199	CcSEcCtD
Bromocriptine—Oedema—Prednisone—Crohn's disease	0.000757	0.00192	CcSEcCtD
Bromocriptine—Infection—Prednisone—Crohn's disease	0.000752	0.00191	CcSEcCtD
Bromocriptine—Shock—Prednisone—Crohn's disease	0.000745	0.00189	CcSEcCtD
Bromocriptine—Nervous system disorder—Prednisone—Crohn's disease	0.000743	0.00188	CcSEcCtD
Bromocriptine—Tachycardia—Prednisone—Crohn's disease	0.000739	0.00187	CcSEcCtD
Bromocriptine—Skin disorder—Prednisone—Crohn's disease	0.000736	0.00186	CcSEcCtD
Bromocriptine—Anorexia—Prednisone—Crohn's disease	0.000722	0.00183	CcSEcCtD
Bromocriptine—Insomnia—Prednisone—Crohn's disease	0.000685	0.00173	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisone—Crohn's disease	0.00068	0.00172	CcSEcCtD
Bromocriptine—Dyspepsia—Prednisone—Crohn's disease	0.000667	0.00169	CcSEcCtD
Bromocriptine—Decreased appetite—Prednisone—Crohn's disease	0.000658	0.00167	CcSEcCtD
Bromocriptine—Fatigue—Prednisone—Crohn's disease	0.000653	0.00165	CcSEcCtD
Bromocriptine—Constipation—Prednisone—Crohn's disease	0.000648	0.00164	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisone—Crohn's disease	0.000624	0.00158	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000619	0.00157	CcSEcCtD
Bromocriptine—Urticaria—Prednisone—Crohn's disease	0.000602	0.00152	CcSEcCtD
Bromocriptine—Abdominal pain—Prednisone—Crohn's disease	0.000599	0.00152	CcSEcCtD
Bromocriptine—Body temperature increased—Prednisone—Crohn's disease	0.000599	0.00152	CcSEcCtD
Bromocriptine—ABCB1—lymph node—Crohn's disease	0.000586	0.0031	CbGeAlD
Bromocriptine—Asthenia—Prednisone—Crohn's disease	0.000543	0.00138	CcSEcCtD
Bromocriptine—Diarrhoea—Prednisone—Crohn's disease	0.000518	0.00131	CcSEcCtD
Bromocriptine—Dizziness—Prednisone—Crohn's disease	0.000501	0.00127	CcSEcCtD
Bromocriptine—Vomiting—Prednisone—Crohn's disease	0.000481	0.00122	CcSEcCtD
Bromocriptine—Rash—Prednisone—Crohn's disease	0.000477	0.00121	CcSEcCtD
Bromocriptine—Dermatitis—Prednisone—Crohn's disease	0.000477	0.00121	CcSEcCtD
Bromocriptine—Headache—Prednisone—Crohn's disease	0.000474	0.0012	CcSEcCtD
Bromocriptine—Nausea—Prednisone—Crohn's disease	0.00045	0.00114	CcSEcCtD
Bromocriptine—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	5.71e-05	0.000137	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	5.7e-05	0.000137	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	5.69e-05	0.000137	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	5.68e-05	0.000137	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—JAK2—Crohn's disease	5.68e-05	0.000137	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	5.67e-05	0.000136	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—FADS1—Crohn's disease	5.67e-05	0.000136	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	5.65e-05	0.000136	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	5.64e-05	0.000136	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL2RA—Crohn's disease	5.62e-05	0.000135	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—MTMR3—Crohn's disease	5.62e-05	0.000135	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	5.59e-05	0.000134	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	5.57e-05	0.000134	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	5.55e-05	0.000134	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	5.5e-05	0.000132	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SMAD3—Crohn's disease	5.46e-05	0.000131	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL3—Crohn's disease	5.45e-05	0.000131	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	5.45e-05	0.000131	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	5.44e-05	0.000131	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	5.42e-05	0.00013	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	5.42e-05	0.00013	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	5.41e-05	0.00013	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	5.39e-05	0.00013	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SMAD3—Crohn's disease	5.39e-05	0.00013	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	5.39e-05	0.00013	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	5.37e-05	0.000129	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL3—Crohn's disease	5.36e-05	0.000129	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TYK2—Crohn's disease	5.36e-05	0.000129	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	5.36e-05	0.000129	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GPX4—Crohn's disease	5.31e-05	0.000128	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	5.27e-05	0.000127	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	5.27e-05	0.000127	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	5.27e-05	0.000127	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	5.25e-05	0.000126	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	5.25e-05	0.000126	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	5.2e-05	0.000125	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	5.19e-05	0.000125	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	5.19e-05	0.000125	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	5.19e-05	0.000125	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	5.18e-05	0.000125	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	5.18e-05	0.000125	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	5.18e-05	0.000125	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	5.17e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	5.16e-05	0.000124	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	5.16e-05	0.000124	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	5.15e-05	0.000124	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GCKR—Crohn's disease	5.13e-05	0.000123	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	5.13e-05	0.000123	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—JAK2—Crohn's disease	5.12e-05	0.000123	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	5.08e-05	0.000122	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL2RA—Crohn's disease	5.06e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	5.02e-05	0.000121	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	5e-05	0.00012	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	4.99e-05	0.00012	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL2RA—Crohn's disease	4.99e-05	0.00012	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	4.97e-05	0.00012	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	4.95e-05	0.000119	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	4.95e-05	0.000119	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	4.94e-05	0.000119	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	4.92e-05	0.000118	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	4.91e-05	0.000118	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	4.88e-05	0.000117	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	4.87e-05	0.000117	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	4.81e-05	0.000116	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	4.79e-05	0.000115	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	4.79e-05	0.000115	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	4.78e-05	0.000115	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	4.74e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	4.72e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	4.72e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	4.71e-05	0.000113	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	4.71e-05	0.000113	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	4.7e-05	0.000113	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	4.7e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	4.68e-05	0.000113	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	4.67e-05	0.000112	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—CXCL8—Crohn's disease	4.67e-05	0.000112	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	4.61e-05	0.000111	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	4.6e-05	0.000111	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	4.56e-05	0.00011	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	4.55e-05	0.000109	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	4.55e-05	0.000109	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	4.52e-05	0.000109	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	4.51e-05	0.000108	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	4.49e-05	0.000108	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	4.48e-05	0.000108	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	4.47e-05	0.000108	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—IL6—Crohn's disease	4.44e-05	0.000107	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	4.39e-05	0.000106	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—FADS1—Crohn's disease	4.38e-05	0.000105	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	4.37e-05	0.000105	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	4.37e-05	0.000105	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.36e-05	0.000105	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	4.35e-05	0.000105	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	4.35e-05	0.000104	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	4.33e-05	0.000104	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	4.3e-05	0.000103	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	4.3e-05	0.000103	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	4.28e-05	0.000103	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	4.28e-05	0.000103	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	4.28e-05	0.000103	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	4.21e-05	0.000101	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	4.21e-05	0.000101	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	4.19e-05	0.000101	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	4.14e-05	9.96e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TYK2—Crohn's disease	4.14e-05	9.96e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TYK2—Crohn's disease	4.14e-05	9.94e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	4.12e-05	9.92e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TYK2—Crohn's disease	4.11e-05	9.88e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GPX4—Crohn's disease	4.1e-05	9.85e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	4.08e-05	9.8e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	4.06e-05	9.76e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TYK2—Crohn's disease	4.02e-05	9.67e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	3.97e-05	9.56e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	3.97e-05	9.54e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TYK2—Crohn's disease	3.96e-05	9.52e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GCKR—Crohn's disease	3.96e-05	9.51e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—JAK2—Crohn's disease	3.95e-05	9.5e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—JAK2—Crohn's disease	3.95e-05	9.49e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—JAK2—Crohn's disease	3.92e-05	9.42e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	3.91e-05	9.4e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	3.9e-05	9.38e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	3.89e-05	9.35e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—JAK2—Crohn's disease	3.84e-05	9.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	3.82e-05	9.19e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	3.82e-05	9.18e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TYK2—Crohn's disease	3.78e-05	9.09e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—JAK2—Crohn's disease	3.78e-05	9.08e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	3.76e-05	9.04e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—STAT3—Crohn's disease	3.76e-05	9.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	3.69e-05	8.88e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	3.68e-05	8.85e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.66e-05	8.81e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—ALB—Crohn's disease	3.64e-05	8.75e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—JAK2—Crohn's disease	3.61e-05	8.67e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CXCL8—Crohn's disease	3.6e-05	8.67e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CXCL8—Crohn's disease	3.6e-05	8.66e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	3.58e-05	8.6e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TYK2—Crohn's disease	3.56e-05	8.57e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	3.55e-05	8.54e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	3.52e-05	8.46e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TYK2—Crohn's disease	3.52e-05	8.46e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	3.5e-05	8.42e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CXCL8—Crohn's disease	3.45e-05	8.29e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL6—Crohn's disease	3.43e-05	8.24e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL6—Crohn's disease	3.42e-05	8.23e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	3.42e-05	8.22e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL6—Crohn's disease	3.4e-05	8.18e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—JAK2—Crohn's disease	3.4e-05	8.18e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	3.35e-05	8.07e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—JAK2—Crohn's disease	3.35e-05	8.07e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL6—Crohn's disease	3.33e-05	8.01e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	3.29e-05	7.91e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL6—Crohn's disease	3.28e-05	7.88e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.21e-05	7.71e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TYK2—Crohn's disease	3.2e-05	7.7e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PTGS2—Crohn's disease	3.18e-05	7.66e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	3.17e-05	7.63e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL6—Crohn's disease	3.13e-05	7.52e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CXCL8—Crohn's disease	3.1e-05	7.46e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TYK2—Crohn's disease	3.06e-05	7.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	3.06e-05	7.36e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CXCL8—Crohn's disease	3.06e-05	7.36e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—JAK2—Crohn's disease	3.06e-05	7.35e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	3.05e-05	7.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	3.03e-05	7.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	2.97e-05	7.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—ALB—Crohn's disease	2.96e-05	7.11e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL6—Crohn's disease	2.95e-05	7.09e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—JAK2—Crohn's disease	2.92e-05	7.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	2.92e-05	7.02e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	2.91e-05	7e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL6—Crohn's disease	2.91e-05	7e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	2.91e-05	6.99e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—STAT3—Crohn's disease	2.9e-05	6.97e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—STAT3—Crohn's disease	2.9e-05	6.96e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—STAT3—Crohn's disease	2.88e-05	6.92e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	2.83e-05	6.8e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—STAT3—Crohn's disease	2.82e-05	6.77e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	2.79e-05	6.71e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	2.78e-05	6.69e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—STAT3—Crohn's disease	2.77e-05	6.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	2.76e-05	6.65e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TYK2—Crohn's disease	2.69e-05	6.47e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	2.67e-05	6.42e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	2.65e-05	6.38e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL6—Crohn's disease	2.65e-05	6.38e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	2.65e-05	6.37e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—STAT3—Crohn's disease	2.65e-05	6.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	2.63e-05	6.32e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL6—Crohn's disease	2.62e-05	6.31e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	2.59e-05	6.23e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTGS2—Crohn's disease	2.59e-05	6.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	2.58e-05	6.21e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—JAK2—Crohn's disease	2.57e-05	6.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	2.54e-05	6.11e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—Crohn's disease	2.54e-05	6.1e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	2.53e-05	6.07e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	2.52e-05	6.07e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—STAT3—Crohn's disease	2.5e-05	6e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	2.47e-05	5.95e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	2.46e-05	5.92e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—STAT3—Crohn's disease	2.46e-05	5.92e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	2.46e-05	5.9e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	2.42e-05	5.81e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	2.41e-05	5.79e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	2.34e-05	5.63e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.31e-05	5.54e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	2.3e-05	5.53e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	2.26e-05	5.43e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—Crohn's disease	2.24e-05	5.39e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—Crohn's disease	2.23e-05	5.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	2.22e-05	5.35e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.19e-05	5.27e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	2.15e-05	5.16e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.15e-05	5.16e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	2.13e-05	5.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	2.1e-05	5.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	2.08e-05	4.99e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—Crohn's disease	2.04e-05	4.91e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	2.04e-05	4.91e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—Crohn's disease	2.02e-05	4.87e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—Crohn's disease	2.02e-05	4.86e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—Crohn's disease	2.01e-05	4.83e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	1.99e-05	4.8e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—Crohn's disease	1.97e-05	4.73e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—Crohn's disease	1.94e-05	4.66e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—Crohn's disease	1.88e-05	4.53e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	1.85e-05	4.46e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—Crohn's disease	1.85e-05	4.44e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	1.82e-05	4.36e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—Crohn's disease	1.79e-05	4.3e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—Crohn's disease	1.74e-05	4.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—Crohn's disease	1.72e-05	4.14e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—Crohn's disease	1.72e-05	4.14e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	1.69e-05	4.06e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—Crohn's disease	1.63e-05	3.92e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—Crohn's disease	1.57e-05	3.77e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—Crohn's disease	1.55e-05	3.73e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—Crohn's disease	1.5e-05	3.6e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—Crohn's disease	1.49e-05	3.59e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—Crohn's disease	1.45e-05	3.49e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.43e-05	3.43e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—Crohn's disease	1.43e-05	3.43e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—Crohn's disease	1.32e-05	3.16e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.29e-05	3.11e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	1.27e-05	3.05e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—Crohn's disease	1.26e-05	3.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	1.18e-05	2.83e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.1e-05	2.65e-05	CbGpPWpGaD
